These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2570132)

  • 1. Monoaminergic neurotransmitters in Alzheimer's disease. An HPLC study comparing presenile familial and sporadic senile cases.
    Herregodts P; Bruyland M; De Keyser J; Solheid C; Michotte Y; Ebinger G
    J Neurol Sci; 1989 Aug; 92(1):101-16. PubMed ID: 2570132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of biogenic amines and their catabolites in brains from patients with Alzheimer's disease.
    Ebinger G; Bruyland M; Martin JJ; Herregodts P; Cras P; Michotte Y; Gommé L
    J Neurol Sci; 1987 Feb; 77(2-3):267-83. PubMed ID: 3819769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurochemistry of Alzheimer's disease.
    Engelborghs S; De Deyn PP
    Acta Neurol Belg; 1997 Jun; 97(2):67-84. PubMed ID: 9246374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
    Nazarali AJ; Reynolds GP
    Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients.
    Storga D; Vrecko K; Birkmayer JG; Reibnegger G
    Neurosci Lett; 1996 Jan; 203(1):29-32. PubMed ID: 8742039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senile dementia and presenile dementia.
    Nakamura S
    Tohoku J Exp Med; 1990 Aug; 161 Suppl():49-60. PubMed ID: 1707190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine distribution in the brain of caiman sclerops.
    Doshi E; Huggins SE
    Comp Biochem Physiol C Comp Pharmacol; 1977; 56(2):85-8. PubMed ID: 15783
    [No Abstract]   [Full Text] [Related]  

  • 10. A rapid and sensitive method for the analysis of brain monoamine neurotransmitters using ultra-fast liquid chromatography coupled to electrochemical detection.
    Parrot S; Neuzeret PC; Denoroy L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3871-8. PubMed ID: 22100552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of monoamines in post-mortem brains from patients with diffuse Lewy body disease.
    Ohara K; Kondo N; Ohara K
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):311-7. PubMed ID: 9608603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
    Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
    Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.
    Sparks DL; Markesbery WR; Slevin JT
    Ann Neurol; 1986 Jun; 19(6):602-4. PubMed ID: 2425718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional changes in monoamines and metabolites following defensive aggression in the rat.
    Kantak KM; Hegstrand LR; Eichelman B
    Brain Res Bull; 1984 Mar; 12(3):227-32. PubMed ID: 6202379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catecholamines and serotonin of the brain after trauma of certain centers and nerve pathways].
    Narkiewicz O
    Pol Tyg Lek; 1970 Sep; 25(37):1430-2. PubMed ID: 4919170
    [No Abstract]   [Full Text] [Related]  

  • 16. The establishment of a sensitive method in determining different neurotransmitters simultaneously in rat brains by using liquid chromatography-electrospray tandem mass spectrometry.
    Zhu KY; Fu Q; Leung KW; Wong ZC; Choi RC; Tsim KW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):737-42. PubMed ID: 21377429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of liquid chromatographic-fluorometric systems in neurochemistry.
    Anderson GM; Young JG
    Life Sci; 1981 Feb; 28(5):507-17. PubMed ID: 7010039
    [No Abstract]   [Full Text] [Related]  

  • 18. A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation.
    Kilpatrick IC; Jones MW; Phillipson OT
    J Neurochem; 1986 Jun; 46(6):1865-76. PubMed ID: 2422325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantitation of norepinephrine, dopamine and serotonin in brain during and following chronic naltrexone administration.
    Baron SA; Testa FM; Gintzler AR
    Brain Res; 1985 Aug; 340(1):192-8. PubMed ID: 2862958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine analysis with strong cation exchange column liquid chromatography-peroxyoxalate chemiluminescence reaction detection.
    Tsunoda M; Funatsu T
    Anal Bioanal Chem; 2012 Jan; 402(3):1393-7. PubMed ID: 22076313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.